Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Andree Kurniawan
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 543-550
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Sexual dimorphism in COVID-19: potential clinical and public health implications
Nicole Bechmann, Andreas Barthel, Andreas Schedl, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 3, pp. 221-230
Open Access | Times Cited: 105
Diabetes and the COVID-19 pandemic
Kamlesh Khunti, Jonathan Valabhji, Shivani Misra
Diabetologia (2022) Vol. 66, Iss. 2, pp. 255-266
Open Access | Times Cited: 78
COVID-19 and Diabetes
Awadhesh Kumar Singh, Kamlesh Khunti
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 129-147
Closed Access | Times Cited: 80
Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis
Nam Nhat Nguyen, Dung Si Ho, Hung Song Nguyen, et al.
Metabolism (2022) Vol. 131, pp. 155196-155196
Open Access | Times Cited: 68
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
Chengxia Kan, Yang Zhang, Fang Han, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 59
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Diabetes Research and Clinical Practice (2021) Vol. 179, pp. 109031-109031
Open Access | Times Cited: 52
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Tianli Zhang, Tong Xiang, Shijie Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies
Timotius Ivan Hariyanto, Devina Adella Halim, Jane Rosalind, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 44
Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression
Engelberta Pardamean, Waskita Roan, Karina Terry Amartini Iskandar, et al.
General Hospital Psychiatry (2022) Vol. 75, pp. 61-67
Open Access | Times Cited: 30
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 40
Insulin Treatment May Increase Adverse Outcomes in Patients With COVID-19 and Diabetes: A Systematic Review and Meta-Analysis
Yan Yang, Zixin Cai, Jingjing Zhang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 39
Validation of Neutrophil-to-Lymphocyte Ratio Cut-off Value Associated with High In-Hospital Mortality in COVID-19 Patients
Halil Yıldız, Diego Castanares‐Zapatero, Guillaume Pierman, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 5111-5117
Open Access | Times Cited: 32
Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma
Xiaoyan Ding, Nan Ye, Minyue Qiu, et al.
Chemico-Biological Interactions (2022) Vol. 353, pp. 109796-109796
Open Access | Times Cited: 19
Psychiatric sequelae in COVID-19 survivors: A narrative review
Cynthia Putri, Jessie Arisa, Joshua Edward Hananto, et al.
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 821-829
Open Access | Times Cited: 27
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies
Zhi-Hui Song, Qiao-Ming Huang, Shan-Shan Xu, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 4, pp. 773-787
Closed Access | Times Cited: 3
Glucose-lowering drugs and outcome from COVID-19 among patients with type 2 diabetes mellitus: a population-wide analysis in Hong Kong
Andrea O. Y. Luk, Terry Cheuk‐Fung Yip, Xinge Zhang, et al.
BMJ Open (2021) Vol. 11, Iss. 10, pp. e052310-e052310
Open Access | Times Cited: 20
Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension
Onur Elbasan, Feyza Bayram, Ceyda Dinçer Yazan, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288338-e0288338
Open Access | Times Cited: 7
Antiviral properties of milk proteins and peptides against SARS-COV-2: A review
Parminder Singh, Janak Dhakal, Pavan Kumar
Journal of Functional Foods (2024) Vol. 117, pp. 106237-106237
Open Access | Times Cited: 2
Treatment with a DPP-4 inhibitor at time of hospital admission for COVID-19 is not associated with improved clinical outcomes: data from the COVID-PREDICT cohort study in The Netherlands
Rick I. Meijer, Trynke Hoekstra, Niels C. Gritters van den Oever, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 2, pp. 1155-1160
Open Access | Times Cited: 13
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
Rıfat Emral, Cem Haymana, İbrahim Demirci, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 11, pp. 2857-2870
Open Access | Times Cited: 13
Importance of diabetes management during the COVID-19 pandemic
Jeremy Pettus, NEIL SKOLNIK
Postgraduate Medicine (2021) Vol. 133, Iss. 8, pp. 912-919
Open Access | Times Cited: 12
Efficacy and Safety of Sitagliptin in the Treatment of COVID-19
Ehab Mudher Mikhael, Siew Chin Ong, Siti Maisharah Sheikh Ghadzi
Journal of Pharmacy Practice (2022) Vol. 36, Iss. 4, pp. 980-987
Open Access | Times Cited: 8
COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19?
Pranav Kumar Prabhakar, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Molecular Pharmacology (2022) Vol. 16, Iss. 4, pp. 494-506
Closed Access | Times Cited: 8
Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis
Abby C. Lee, Wei Tse Li, Lauren Apostol, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3755-3764
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top